home / stock / brax:cc / brax:cc news

BRAX:CC News and Press, Braxia Scientific Corp. From 02/27/23

Stock Information
Company Name: Braxia Scientific Corp.
Stock Symbol: BRAX:CC
Market: CNQC
Menu
BRAX:CC BRAX:CC Quote BRAX:CC Short BRAX:CC News BRAX:CC Articles BRAX:CC Message Board
Get BRAX:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
BRAX:CC - Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement

Toronto, Ontario--(Newsfile Corp. - February 27, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is pleased to annou...
BRAX:CC - REPEAT - Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics

LOS ANGELES, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is pleased to announce the Company has successfully completed the acquisition of Serenity Health, LLC, (“Serenity”) ...

BRAX:CC - Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals

--News Direct-- Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has agreed to a non-binding amended and restated letter of intent for a business combination with Irwin Naturals Inc. McIntyre told Proactive the transaction assembles an ...

BRAX:CC - Braxia Scientific Announces Offering up to $1.5 Million, Braxia Management to Participate in Concurrent Private Placement

Toronto, Ontario--(Newsfile Corp. - February 7, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is pleased to announce an...
BRAX:CC - RETRANSMISSION: Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint of 17 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend acces...

BRAX:CC - Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

Strategic transaction assembles an experienced management and scientific team world-renowned in mental health treatment, research and development Establishes large footprint of 17 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend acces...

BRAX:CC - Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.

Toronto, Ontario--(Newsfile Corp. - January 10, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, is proud ...
BRAX:CC - Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US

LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) , is proud to announce it has signed a Letter of Intent entering into a partnership with Braxia Scientific Corp. (“Braxia S...

BRAX:CC - Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America

Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America Canada NewsWire Braxia Health clinic ketamine treatments up 34.5% YoY in Q2 2023 and revenue up 18% YoY Expan...

BRAX:CC - Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders Canada NewsWire TORONTO , Nov. 1, 2022 /CNW/ - Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical res...
Previous 10 Next 10